Endomag makes FT’s 5th Annual ‘FT 1000’ listing

Tue, Mar 2, 2021

The Financial Times annual listing compiles the top 1000 companies in Europe as measured by revenue growth. Park occupier Endomag is the 7th highest rated Healthcare company featured.

Endomag is a global technology company that believes everyone deserves a better standard of cancer care. Many of the world’s leading physicians and hospitals use the company’s technologies to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is.

Originally founded in 2007 by professors at University College London (UCL) and the University of Houston, Endomag harnesses the power of magnetics to enable a better standard of cancer care. The heart of the company’s product platform is the Sentimag® localisation system. The Sentimag® system features a probe which works like a metal detector, and when placed near the skin’s surface is used to detect Endomag’s magnetic seed (Magseed®) or liquidtracer (Magtrace®), for tissue localisation and sentinel node biopsy procedures.

Endomag is headquartered in Cambridge, UK, with an office in Austin, Texas. To date, the company has helped tens of thousands of women around the world access more precise and less invasive breast cancer care. To learn more visit.

Congratulations to the Endomag team!

The full ‘FT 1000: Europe’s Fastest Growing Companies of 2021’ listing can be found via www.ft.com


Get in touch

Park Management

Carl Williams
T: +44 (0)1223 347 066

Email Me

Innovation Centre

Miranda Edwards
T: +44 (0)1223 420 252

Email Me


William Clarke
T: +44 (0)1223 347 294

Email Me